Thank you!
Your support is sustaining the future of local news in our communities.

A variant with 50 mutations: omicron

Afew months ago, we were enjoying the reopening of civil society. But events intervened. First, the protection of two-dose vaccines started to subside. Second, unvaccinated patients, including children, were sickened by the furiously infectious omicron variant of SARS-CoV-2. More patients survive the omicron virus many experts say, but there are so many that the medical system can still be overwhelmed. Nursing and medical staff are exhausted, and patients with other diseases or conditions may not get the treatments they need.

On Jan. 6, in New York, the number of people with positive tests was 22.5%; in Connecticut, 29.1% and in Massachusetts, 21.8%. By the time you read this these numbers will be higher. Infections do not go on indefinitely — eventually there will be no uninfected or unvaccinated people.

Epidemiologists, or rather the clan of mathematical modelers among them, predict a crash in the number of infections by early February 2022. That may signal herd immunity and a change from pandemic status to endemic. The latter causes sporadic infection at low levels and tends not to overwhelm hospitals or harm the economy.

Omicron appeared in Botswana and South Africa in November 2021.  South African physicians have seen mild disease, and the infection is declining there. In the UK, some reports said severity is unaffected; others that the disease caused by omicron is milder than that caused by the Delta variant. The CDC’s Morbidity and Mortality Weekly Reports appears every Thursday and is online. It provides no conclusions yet on the severity of omicron on unvaccinated people, including children. Deaths do not seem to be increasing as rapidly as infections. In the early stage of a new infection or treatment, information comes in press reports, which can be written with more enthusiasm than data.  We will know more soon.

There are about 50 mutations in the omicron virus and a dozen in the delta variant. A virus-specific enzyme copies the RNA genome of SARS-CoV-2 but makes errors—30 have accumulated in the omicron spike protein and 20 in other omicron genes. Think of them as typos that the virus has not corrected. If the typos help the virus survive counterattack by the immune system, the typos (mutations) are retained. Each infected lung cell can make thousands of viruses, so the infection spreads fast. Since November, omicron, which makes about five times more virus than the original strain, has nearly replaced the delta variant.

You may wonder how any living thing survives viral onslaughts; the answer is that sometimes they don’t. When we do survive, it is because the human immune system is a wondrous collection of rapid defenses. Immunology is the science of engaging these defenses before a pathogen does. Think of it as an ambush. Immunity is as complicated as it is vital. I taught a course called The Cell Biology of Tissues and Organelles for beginning medical and dental students for 25 years.  Immunology flummoxed the students. It takes time to learn.

A group at Baylor College of Medicine and The Texas Children’s Hospital headed by Elena Bottazzi and Peter Hotez has fashioned a vaccine that does not employ an mRNA, but rather fragments of viral protein. The vaccine does not require refrigeration; a dose costs $1.50 and it is not patent protected. In India, the vaccine, called Corbevax, has been approved. It is an older method, but sometimes that is best.  A recent issue of Nature has a fine review on the status of COVID vaccines written for non-scientists.  Type “How COVID Vaccines Shaped 2021” into your browser to read it.

Treatments are being developed that stop infections, including immunoglobulins that can be inhaled. In the same vein, nanobodies, tiny antibodies made by Camelids (alpacas) neutralize omicron or other viruses. Think of an asthma inhaler spraying antibodies directly onto the virus in your lungs.

Drugs to inhibit viruses are a recent development — in the 1990s for HIV and now for other viruses. Pfizer has a drug called Paxlovid, which blocks the cleavage of viral proteins into functional units.  It is highly effective early after symptoms of COVID have appeared.  There are limited supplies, and the drug is tricky to make, but it will be in use shortly.

The Merck drug Molnupiravir blocks the enzyme that copies the virus genome. Molnupiravir is less effective at preventing symptoms that Paxlovid, but it interesting (to me) because it appear to inhibit other unpleasant RNA viruses. These include influenza; RSV, respiratory syncytial virus (a major cause of ER visits by children); norovirus (infections on cruise ships); Chikungunya virus (a mosquito-borne virus that causes severe joint pain); Venezuelan equine encephalitis virus); and hepatitis C. Perhaps we are at the beginning of a vast improvement in antiviral drug therapy.  Pray for it.

In the meantime, the best thing to do is get your vaccine and booster.  Let’s see if the epidemiologists are right and the peak comes soon. Watch positivity. Watch hospital admissions. Watch deaths from omicron. And hope for the best.

 

Rich Kessin is Emeritus Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center.  Email Richard.Kessin@gmail.com.  See other columns on his website: Richardkessin.com.

The views expressed here are not necessarily those of The Lakeville Journal and The Journal does not support or oppose candidates for public office.

Latest News

Francis Lynehan

Francis Lynehan

DOVER PLAINS — Francis “Butch” Lynehan, 75, a twenty-year resident of Dover Plains, New York, formerly of Sharon, passed away unexpectedly on Thursday, May 7, 2026 at Vassar Bros. Medical Center in Poughkeepsie, New York.

Born Aug. 29, 1950, in Sharon, he was the son of the late William W. and Nellie (Kluun) Lynehan.

Keep ReadingShow less

Richard McGriff

Richard McGriff

TACONIC — Richard McGriff died unexpectedly on May 16, 2026. This is a collection of loving reminiscences.

With a smile like that and a laugh like that and a soul like that, how could you not love him? Macey Levin and Gloria Miller

Keep ReadingShow less
Juneteenth graduation celebrates Berkshire’s next generation of leaders

Cohort 2026 members Abigail Horace, Adam Liccardi, Adrian Lynch, Cameo Brown, Chauncey Dozier, Claudette Grant, Erline Saintilet, Harmony Edwards, Kamayue Gomes, Mackenzie Colvin, Otis West, Shadre Domingo, TJ West and Tyeesha Keele-Kedroe and Blackshires’ leadership team John Lewis, Patrick Danahey, Dubois Thomas and Julie Haagenson gather at the Blackshires City Hall Fishbowl alongside Mayor Peter Marchetti and city officials Michael Obasohan, Brandon Gill, Katherine VanBramer, Heather Brazeau, Justine Dodds and Jesse Tobin McCauley.

Provided

When designer Abigail Horace joined the Blackshires Leadership Accelerator, she was looking for support as the founder of the Black Berkshires Social Club, which creates culturally grounded social spaces for Black and BIPOC residents in the region. What she found was something deeper: a community of peers invested in one another’s success.

“Finding Blackshires has been transformative,” Horace said. “Being a BIPOC founder in this region can feel isolating, and this community has changed that. They see my work, champion my business and have opened doors I couldn’t have opened alone.”

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Forged by curiosity: Art, craftsmanship and big fun with Izzy Fitch

Izzy Fitch at Battle Hill Forge in Wassaic.

Madi Long
I’m not really inventing anything new. I just tweak it a little bit.— Izzy Fitch

A steel praying mantis stands among garden accents at Battle Hill Forge in Wassaic, its folded forelegs ready for prayer and mischief in equal measure.

“She’s very nice,” said blacksmith, sculptor and Battle Hill Forge owner Izzy Fitch, patting the giant insect affectionately. Then he added, “Just don’t go out to dinner with her.”

Keep ReadingShow less
Unexpected subjects, familiar beauty in new Kent exhibits
Millerton-based artist Alexis England with her flamingo and mandrill portraits at Peggy Mercury in Kent.
D.H. Callahan

Kent Barns was alive with art on Saturday, June 13, as three new shows opened at Peggy Mercury and Kenise Barnes Fine Art, featuring a variety of fascinating paintings and drawings from four local artists.

Peggy Mercury, which in just two years has earned a reputation for curating remarkable collections of fine beauty products and accessories, continues to find exciting art to complement its offerings. The new show, “Portraits,” features four pairs of paintings by Millerton-based artist Alexis England. The “portraits” she paints, however, feature some pretty unexpected sitters.

Keep ReadingShow less
Stonewood Farm launches chefs in residence program
Jocelyn Ueng is the first Chef in Residence at Stonewood Farm.
Provided

Stonewood Farm in Millbrook is expanding its educational and community food programs this summer with the launch of a new Chefs in Residence program, an eight-week immersion that brings culinary professionals to the nonprofit farm to live, cook, teach and work alongside farmers.

The program is led by Kristen Essig, Stonewood’s director of culinary outreach and development, an award-winning chef whose background includes work with Emeril Lagasse and multiple James Beard Award nominations.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.